BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 3, 2012
View Archived Issues
Plant-based platform developed for production of antimalarial drug
Read More
Takeda identifies benzazepine derivatives for treatment of obesity
Read More
Selective GlyT2 inhibitor shows promising analgesic effects in vivo
Read More
Mochida reports potent in vivo analgesic activity for proprietary drug
Read More
European team generates water-stable, helicate-like products as potential antimicrobials
Read More
Oleanolic acid derivative shows promise in model of MS
Read More
New panthetheinase inhibitors presented to treat malaria
Read More
Exonhit discloses novel tubulin polymerization inhibitors
Read More
Boehringer Ingelheim synthesizes novel chemokine CCR2 receptor antagonists
Read More
GlaxoSmithKline enrolling toddlers in phase I pneumococcal vaccine trial
Read More
Recruitment begins in phase III BEACON study
Read More
New phosphodiesterase inhibitors prepared at IntraCellular Therapies
Read More
Cardiolynx patents new pioglitazone derivatives
Read More
Novel peptide conjugates for bacterial infections designed in Canada
Read More
Lundbeck launches antiepileptic tablet in U.S.
Read More
Resubmitted pixantrone NDA to be reviewed by FDA's ODAC
Read More
New alpha-glucosidase inhibitors developed in Spain
Read More
Phase IIb trial of photodynamic therapy for cervical intraepithelial neoplasia advances
Read More
Phylogica enters new collaboration involving Phylomer peptide platform
Read More
Enrollment in phase II KRN-321 study begins in Japan
Read More
Agile Therapeutics completes phase III program for contraceptive patch
Read More
Advaxis to raise additional funding with sale of convertible promissory notes
Read More
Tivozanib superior to sorafenib in phase III study
Read More
Alnylam reports encouraging preclinical data on RNAi therapeutic for Huntington's disease
Read More
Glenmark begins pivotal study of antidiarrheal drug in India
Read More